ES553415A0 - Un procedimiento para la preparacion de derivados de ariletanolamina. - Google Patents

Un procedimiento para la preparacion de derivados de ariletanolamina.

Info

Publication number
ES553415A0
ES553415A0 ES553415A ES553415A ES553415A0 ES 553415 A0 ES553415 A0 ES 553415A0 ES 553415 A ES553415 A ES 553415A ES 553415 A ES553415 A ES 553415A ES 553415 A0 ES553415 A0 ES 553415A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
arylethanolamine derivatives
arylethanolamine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES553415A
Other languages
English (en)
Other versions
ES8802014A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES8802014A1 publication Critical patent/ES8802014A1/es
Publication of ES553415A0 publication Critical patent/ES553415A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Food Science & Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
ES553415A 1985-03-27 1986-03-25 Un procedimiento para la preparacion de derivados de ariletanolamina. Expired ES8802014A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858507942A GB8507942D0 (en) 1985-03-27 1985-03-27 Compounds

Publications (2)

Publication Number Publication Date
ES8802014A1 ES8802014A1 (es) 1988-03-16
ES553415A0 true ES553415A0 (es) 1988-03-16

Family

ID=10576719

Family Applications (1)

Application Number Title Priority Date Filing Date
ES553415A Expired ES8802014A1 (es) 1985-03-27 1986-03-25 Un procedimiento para la preparacion de derivados de ariletanolamina.

Country Status (9)

Country Link
EP (1) EP0196849A3 (es)
JP (1) JPS61251645A (es)
AU (1) AU5509986A (es)
DK (1) DK145386A (es)
ES (1) ES8802014A1 (es)
GB (1) GB8507942D0 (es)
GR (1) GR860797B (es)
PT (1) PT82294B (es)
ZA (1) ZA862234B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6747387A (en) * 1986-01-11 1987-07-16 Beecham Group Plc Arylethanolamine derivatives
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US6075040A (en) 1996-09-05 2000-06-13 Eli Lilly And Company Selective β3 adrenergic agonists
ATE215369T1 (de) 1996-09-05 2002-04-15 Lilly Co Eli Carbazolanaloge als selektive beta3-adrenergische agonisten
CO5011072A1 (es) * 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
US6713651B1 (en) 1999-06-07 2004-03-30 Theravance, Inc. β2-adrenergic receptor agonists
US6362371B1 (en) 1998-06-08 2002-03-26 Advanced Medicine, Inc. β2- adrenergic receptor agonists
US6683115B2 (en) 1999-06-02 2004-01-27 Theravance, Inc. β2-adrenergic receptor agonists
US6593497B1 (en) 1999-06-02 2003-07-15 Theravance, Inc. β2-adrenergic receptor agonists
UA73965C2 (en) 1999-12-08 2005-10-17 Theravance Inc b2 ADRENERGIC RECEPTOR ANTAGONISTS
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
WO2003042160A1 (en) 2001-11-13 2003-05-22 Theravance, Inc. Aryl aniline beta-2 adrenergic receptor agonists
US6747043B2 (en) 2002-05-28 2004-06-08 Theravance, Inc. Alkoxy aryl β2 adrenergic receptor agonists
TW200526547A (en) 2003-09-22 2005-08-16 Theravance Inc Amino-substituted ethylamino β2 adrenergic receptor agonists
TW200531692A (en) 2004-01-12 2005-10-01 Theravance Inc Aryl aniline derivatives as β2 adrenergic receptor agonists
CN1984876A (zh) 2004-06-03 2007-06-20 施万制药 二胺类β2肾上腺素能受体激动剂
WO2006031556A2 (en) 2004-09-10 2006-03-23 Theravance. Inc. Amidine substituted aryl aniline compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786713A (fr) * 1971-07-27 1973-01-25 Sandoz Sa Nouveaux amino-alcools, leur preparation et leur application comme medicaments
DE2303304A1 (de) * 1973-01-24 1973-08-02 Sandoz Ag Verfahren zur herstellung neuer carbocyclischer verbindungen
IL60530A (en) * 1979-08-16 1984-10-31 American Cyanamid Co Animal feed compositions useful as growth promotors and for reduction of fat in animals,comprising phenylethanolamine derivatives and certain such novel compounds

Also Published As

Publication number Publication date
DK145386D0 (da) 1986-03-26
ZA862234B (en) 1986-12-30
EP0196849A2 (en) 1986-10-08
AU5509986A (en) 1986-10-02
PT82294B (en) 1988-01-11
PT82294A (en) 1986-04-01
DK145386A (da) 1986-09-28
GR860797B (en) 1986-07-21
JPS61251645A (ja) 1986-11-08
ES8802014A1 (es) 1988-03-16
EP0196849A3 (en) 1988-01-07
GB8507942D0 (en) 1985-05-01

Similar Documents

Publication Publication Date Title
ES554405A0 (es) Un procedimiento para la preparacion de derivados de aza-indol.
ES551249A0 (es) Un procedimiento para la preparacion de peptidilaminodioles.
ES553044A0 (es) Un procedimiento para la preparacion de nuevos derivados de fenoxialquilaminopirimidina.
ES555834A0 (es) Un procedimiento para la preparacion de nuevas piranopiridinas.
ES544644A0 (es) Un procedimiento para la preparacion de derivados de carboxamidoadenosina.
ES556738A0 (es) Un procedimiento para la preparacion de nuevos piridazinaminas.
ES552189A0 (es) Un procedimiento para la preparacion de derivados de piridimilmidazolidiona.
ES546236A0 (es) Un procedimiento para la preparacion de derivados de bencimidasol.
ES556467A0 (es) Un procedimiento para la preparacion de derivados de furanona.
ES554983A0 (es) Un procedimiento para la preparacion de silileteres.
ES553415A0 (es) Un procedimiento para la preparacion de derivados de ariletanolamina.
ES552297A0 (es) Un procedimiento para la preparacion de nuevos derivados de disacaridos o trisacaridos.
ES550504A0 (es) Un procedimiento para la preparacion de derivados de podofilotoxina.
ES553874A0 (es) Un procedimiento para la preparacion de metanosulfonatos de dioxolano.
ES555369A0 (es) Un procedimiento para la preparacion de un polialquenoilisocianato.
ES554286A0 (es) Un procedimiento para la preparacion de nuevos derivados glicopepticos
ES557772A0 (es) Un procedimiento para la preparacion de epipodofilotoxina
ES553283A0 (es) Un procedimiento para la preparacion de 2-amino-6-cloropurina.
ES554661A0 (es) Un procedimiento para la preparacion de un hidralizado proteico.
ES557839A0 (es) Un procedimiento para la preparacion de derivados de piperazinilo 1-4-disustituidos.
ES555723A0 (es) Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas.
ES557019A0 (es) Un procedimiento para la preparacion de derivados aminicos
ES553703A0 (es) Un procedimiento para la preparacion de vesiculas de fosfoliptidos.
ES552241A0 (es) Un procedimiento para la preparacion de nuevos derivados de pirazolopiridinas.
ES556208A0 (es) Un procedimiento para la preparacion de benzimidazoles.